C. Ferreira

发表

The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well‐differentiated and dedifferentiated liposarcoma oncogenesis. An analysis of 104 tumors

Gaëlle Pérot, P. Terrier, J. Coindre, 2011, Genes, chromosomes & cancer.

From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas

F. Chibon, P. Lagarde, Gaëlle Pérot, 2012, Modern Pathology.

YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas

F. Chibon, P. Lagarde, Gaëlle Pérot, 2010, Genes, chromosomes & cancer.

Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.

S. Puget, B. Geoerger, G. Vassal, 2015, Anti-cancer drugs.

Pediatric ependymomas: will molecular biology change patient management?

J. Grill, C. Ferreira, G. Bergthold, 2011, Current opinion in oncology.

Current and evolving knowledge of prognostic factors for pediatric ependymomas.

S. Puget, F. Andreiuolo, J. Grill, 2013, Future oncology.

YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas

F. Chibon, P. Lagarde, Gaëlle Pérot, 2010, Genes, Chromosomes and Cancer.

Current and evolving knowledge of prognostic factors for pediatric ependymomas.

S. Puget, F. Andreiuolo, J. Grill, 2013, Future oncology.